UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients

Breast cancer research : BCR, 2017-11, Vol.19 (1), p.125-125, Article 125

2017

Volltextzugriff (PDF)

Genotype-guided tamoxifen therapy: time to pause for reflection?

The lancet oncology, 2009-08, Vol.10 (8), p.825-833

2009

Volltextzugriff (PDF)

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5126-5137

2005

Volltextzugriff (PDF)

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

BMC cancer, 2010-06, Vol.10 (1), p.313-313, Article 313

2010

Volltextzugriff (PDF)

Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue

PloS one, 2011-06, Vol.6 (6), p.e20481-e20481

2011

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism

PloS one, 2013-02, Vol.8 (2), p.e56019-e56019

2013

Volltextzugriff (PDF)

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

Breast cancer research and treatment, 2013-09, Vol.141 (2), p.243-248

2013

Volltextzugriff (PDF)

Determination of Choline, Betaine, and Dimethylglycine in Plasma by a High-Throughput Method Based on Normal-Phase Chromatography-Tandem Mass Spectrometry

Clinical chemistry (Baltimore, Md.), 2003-02, Vol.49 (2), p.286-294

2003

Volltextzugriff (PDF)

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

PloS one, 2015-04, Vol.10 (4), p.e0122339-e0122339

2015

Volltextzugriff (PDF)

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Breast cancer research and treatment, 2019-08, Vol.177 (1), p.185-195

2019

Volltextzugriff (PDF)

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

Clinical cancer research, 2004-04, Vol.10 (7), p.2336-2343

2004

Volltextzugriff (PDF)

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3749

2009

Volltextzugriff (PDF)

Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease

European journal of endocrinology, 2011-11, Vol.165 (5), p.761-769

2011

Volltextzugriff (PDF)

Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer

BMC cancer, 2012-06, Vol.12 (1), p.247-247, Article 247

2012

Volltextzugriff (PDF)

Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2015-04, Vol.19 (2), p.113-119

2015

Volltextzugriff (PDF)

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

Breast cancer research and treatment, 2012-07, Vol.134 (2), p.693-700

2012

Volltextzugriff (PDF)

cAMP Response Element-Binding Protein Interacts With and Stimulates the Proteasomal Degradation of the Nuclear Receptor Coactivator GRIP1

Endocrinology (Philadelphia), 2013-04, Vol.154 (4), p.1513-1527

2013

Volltextzugriff (PDF)

A Randomized Trial of Low-Dose Tamoxifen on Breast Cancer Proliferation and Blood Estrogenic Biomarkers

JNCI : Journal of the National Cancer Institute, 2003-06, Vol.95 (11), p.779-790

2003

Volltextzugriff (PDF)

Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells

Biochemical and biophysical research communications, 2014-07, Vol.450 (1), p.360-365

2014

Volltextzugriff (PDF)

Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway

Scandinavian journal of clinical and laboratory investigation, 2010-07, Vol.70 (4), p.281-286

2010

Volltextzugriff (PDF)

Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia

Clinical cancer research, 2009-11, Vol.15 (22), p.7053-7060

2009

Volltextzugriff (PDF)

Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients

Acta oncologica, 2013-05, Vol.52 (4), p.861-861

2013

Volltextzugriff (PDF)

Excretion of Hydroxylated Metabolites of Tamoxifen in Human Bile and Urine

Anticancer research, 2005-11, Vol.25 (6C), p.4487-4492

2005

Volltextzugriff (PDF)

Recruitment of Coactivator Glucocorticoid Receptor Interacting Protein 1 to an Estrogen Receptor Transcription Complex Is Regulated by the 3′,5′-Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase

Endocrinology (Philadelphia), 2008-09, Vol.149 (9), p.4336-4345

2008

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(131)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(89)
Science & Technology
(77)
Biological And Medical Sciences
(70)
Life Sciences & Biomedicine
(70)
Medical Sciences
(60)
Female
(54)
Pharmacology. Drug Treatments
(42)
Middle Aged
(41)
Animals
(33)
Oncology
(33)
Adult
(29)
Aged
(29)
Male
(26)
Breast Neoplasms - Drug Therapy
(19)
Antineoplastic Agents
(17)
Tamoxifen
(17)
Breast Cancer
(16)
Chemotherapy
(15)
Tamoxifen - Administration & Dosage
(15)
Tamoxifen - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients

Genotype-guided tamoxifen therapy: time to pause for reflection?

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue

1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

Determination of Choline, Betaine, and Dimethylglycine in Plasma by a High-Throughput Method Based on Normal-Phase Chromatography-Tandem Mass Spectrometry

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women

Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease

Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer

Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

cAMP Response Element-Binding Protein Interacts With and Stimulates the Proteasomal Degradation of the Nuclear Receptor Coactivator GRIP1

A Randomized Trial of Low-Dose Tamoxifen on Breast Cancer Proliferation and Blood Estrogenic Biomarkers

Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells

Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway

Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia

Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients

Excretion of Hydroxylated Metabolites of Tamoxifen in Human Bile and Urine

Recruitment of Coactivator Glucocorticoid Receptor Interacting Protein 1 to an Estrogen Receptor Transcription Complex Is Regulated by the 3′,5′-Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase

Suchergebnisse filtern